News

RPS offers clients a broad spectrum of outsourcing solutions ranging from globally embedded functional and cross-functional solutions to enhanced global full-service solutions. RPS CEO and chairman Daniel Perlman

Cumberland has informed the US Food and Drug Administration (FDA) of its plan to voluntarily recall these lots of Acetadote as a precautionary measure. According to the company,

MannKind claims that Afrezza is a novel, ultra rapid acting mealtime insulin therapy being developed by MannKind Corporation for the treatment of adult patients with type 1 and

As per the approval, Sinovac is required to conduct each phase of the human clinical trials in accordance with SFDA requirements, to conduct studies to assess safety and

The safety and efficacy of Rhucin for the treatment of HAE attacks were evaluated in two randomized placebo-controlled studies and are supported by four open label treatment studies.

Nuvigil is indicated to improve wakefulness in patients with excessive sleepiness associated with treated obstructive sleep apnea (OSA), shift work disorder (SWD), or narcolepsy. In its letter to

The company expects to recruit around 120 newly-diagnosed GBM patients at treatment centers in the US and India in order to evaluate Azixa combination therapy as a first-line

The Phase 2 trial will investigate whether VT-122 in combination with Nexavar increases ‘Clinical Benefit Response,’ which is a composite measurement of pain, performance status, and lean body

With the initiation of the trial, Emergent BioSolutions has dosed first patient in the trial. According to the company, the Phase I trial is designed to investigate the